Stephanie G Worrell, MD FACS

734 posts

Stephanie G Worrell, MD FACS banner
Stephanie G Worrell, MD FACS

Stephanie G Worrell, MD FACS

@sgworrell

Associate Professor and Section Chief Thoracic Surgery University of Arizona

Katılım Mart 2017
571 Takip Edilen1.4K Takipçiler
Stephanie G Worrell, MD FACS retweetledi
WomenInThoracicSurg
WomenInThoracicSurg@WomenInThoracic·
Register now for the WTS 2nd Annual Conference November 5-6, 2024 at the Omni Amelia Island Resort! Early bird registration is open now through September 1, 2025. Sign up now to take advantage of exclusive pricing! #WTS2025   Learn more & register now: bit.ly/3ZunVfw
WomenInThoracicSurg tweet media
English
0
5
15
1.6K
Stephanie G Worrell, MD FACS retweetledi
Elliot Servais, MD, FACS
Elliot Servais, MD, FACS@ElliotServaisMD·
I’m looking forward to the upcoming @AATSHQ #ITSOS2025 meeting in Boston. Always a terrific meeting focused on multi-disciplinary thoracic surgical oncology! Submit your abstract now and register early!
Elliot Servais, MD, FACS tweet media
English
2
8
21
2.7K
Linda Martin
Linda Martin@LindaMThoracic·
The study I have most anticipated from #ASCO2025 @tssmn @GenThorSurgClub Remember control arm was the 🏆 from ESOPEC- so Rx arm has outperformed that!! Leaves CROSS in the dust for adeno.
Dr Amol Akhade@SuyogCancer

Matterhorn falters on OS EFS HR 0.71 🧪 NEJM MATTERHORN Trial — Periop Durvalumab + FLOT in Resectable Gastric/GEJ Cancer n=948 | Global Phase 3 | FLOT backbone 🎯 Primary Endpoint: Event-Free Survival (EFS) 📊 2-yr EFS: 67.4% vs 58.5% 🕒 Median EFS: NR vs 32.8 mo 🧮 HR 0.71 (95% CI: 0.58–0.86), p < 0.001 🧬 Pathologic CR: 🔹 19.2% vs 7.2% 🔹 RR 2.69 (95% CI: 1.86–3.90) ⚰️ Overall Survival (OS) 📆 24-mo OS: 75.7% vs 70.4% 🕒 Median OS: NR vs 32.8 mo 🧮 HR (0–12m): 0.99 → ❌ no early OS benefit 🧮 HR (≥12m): 0.67 → ✅ delayed IO effect 📉 OS p = 0.03 > alpha (0.0001) → Not significant yet 🛡 Safety 🧾 G3–4 AEs: ~71% both arms 💥 irAEs: 23.2% (vs 7.2%) 🕒 Delayed surgery: ~10% both arms ⚖️ Critique ❗ EFS + pCR ✔️ ❗ OS ✖️ not yet significant ⚠️ No clear biomarker enrichment (PD-L1 or MSI-H) 🛠 Surgical variability not controlled 🧪 Awaiting final OS for SoC impact 🧠 Verdict: Encouraging but not SoC (yet). #NEJM #ASCO25 #GastricCancer #Immunotherapy #Durvalumab #OncoTwitter @dr_yakupergun @GIMedOnc @GIcancerDoc @UGrewalMD @OncoAlert

English
3
7
27
4K
Stephanie G Worrell, MD FACS retweetledi
Shanda Blackmon, MD, MPH
Shanda Blackmon, MD, MPH@ShandaBlackmon·
For the Checkmate 577 prolonged follow-up trial, adjuvant Nivo for pts w eso ca known to have residual dz after rsxn benefitted from sustained superior OS past 5yrs. @ASCO #ASCO2025 #EsophagealCancer
Shanda Blackmon, MD, MPH tweet media
English
1
4
14
1.5K
Stephanie G Worrell, MD FACS retweetledi
AATS
AATS@AATSHQ·
New esophageal cancer research: Outcomes of jejunostomy-tube placement in surgical patients with esophageal cancer. Read the retrospective, multi-institutional study in #JTCVS Open: doi.org/10.1016/j.xjon… @hope_conrad @sgworrell
AATS tweet media
English
0
3
7
1.7K
Stephanie G Worrell, MD FACS retweetledi
Jennifer F Tseng MD MPH
Jennifer F Tseng MD MPH@TsengJennifer·
“Remember, there’s a patient on the other side.” SSAT President Taylor Riall uses her own experience as a cancer patient to challenge us: “It can be hard to show up every day & go the extra mile in a flawed system. But I continue to do so. I challenge you to do the same.” ❤️🙏
Jennifer F Tseng MD MPH tweet media
English
1
8
42
3K
Stephanie G Worrell, MD FACS retweetledi
Daniela
Daniela@Daniela_Molena·
Great talk about the journey to a robotic double lung transplant! Amazing Stephanie H. Chang, MD 👏🏻👏🏻@WomenInThoracic
Daniela tweet media
English
0
9
52
6.5K
Stephanie G Worrell, MD FACS retweetledi
Mara Antonoff, MD, FACS
Mara Antonoff, MD, FACS@maraantonoff·
It was a productive early morning at #AATS2025 with @sgworrell - getting in our runs and meeting with the @WomenInThoracic leadership. Ready for another full day of education, collaboration, and connecting with colleagues here at the @AATSHQ meeting.
Mara Antonoff, MD, FACS tweet mediaMara Antonoff, MD, FACS tweet media
English
1
5
47
2.3K
Stephanie G Worrell, MD FACS retweetledi
Hari B. Keshava
Hari B. Keshava@hari_keshava·
Should we be doing more robotic tracheobronchoplasty?? Simple answer...Yes!! #AATS2025
Hari B. Keshava tweet mediaHari B. Keshava tweet mediaHari B. Keshava tweet mediaHari B. Keshava tweet media
English
1
2
12
820
Stephanie G Worrell, MD FACS retweetledi
Mara Antonoff, MD, FACS
Mara Antonoff, MD, FACS@maraantonoff·
A HUGE thanks to @AATSHQ for supporting @WomenInThoracic, and much gratitude to all who came out to celebrate the WTS last evening at #AATS2025. We are fortunate to have a growing membership and the continuous support of our allies, colleagues, sponsors, and friends.
Mara Antonoff, MD, FACS tweet media
English
1
17
75
3.2K
Stephanie G Worrell, MD FACS retweetledi
Mara Antonoff, MD, FACS
Mara Antonoff, MD, FACS@maraantonoff·
Please join us tomorrow night! All colleagues, mentors, friends, and trainees are welcome. #AATS2025 @WomenSurgeons @WomenInThoracic @AATSHQ
WomenInThoracicSurg@WomenInThoracic

Join us for the AATS/WTS Reception at the 105th AATS Annual Meeting in Seattle! Connect with colleagues and celebrate our community on Friday, May 2, from 5:30–7:30 PM in Theater 3, Exhibit Hall. This event is open to all WTS supporters and members; no registration is required.

English
0
8
31
3K

Keşfet

@TomVargheseJr @WomenSurgeons @AATSHQ @ElliotServaisMD @LindaMThoracic @tssmn @GenThorSurgClub @Daniela_Molena